HCPCS Level IIdrugActive
J0180
Agalsidase beta injection
BETOS: O1E
Effective: 2005-01-01
Description
Injection, agalsidase beta, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Fabrazyme
Manufacturer
Genzyme Corporation
HCPCS Dosage
1 MG
Billing Units
35.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.